1. Home
  2. HNNA vs XGN Comparison

HNNA vs XGN Comparison

Compare HNNA & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hennessy Advisors Inc.

HNNA

Hennessy Advisors Inc.

HOLD

Current Price

$10.10

Market Cap

78.0M

Sector

Finance

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$2.96

Market Cap

71.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNNA
XGN
Founded
1989
2002
Country
United States
United States
Employees
N/A
220
Industry
Investment Managers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.0M
71.2M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
HNNA
XGN
Price
$10.10
$2.96
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.86
AVG Volume (30 Days)
3.8K
214.4K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
5.57%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$8.12
Revenue Next Year
N/A
$13.00
P/E Ratio
$8.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.90
$2.59
52 Week High
$13.19
$12.23

Technical Indicators

Market Signals
Indicator
HNNA
XGN
Relative Strength Index (RSI) 59.30 48.52
Support Level $9.66 $2.61
Resistance Level $10.33 $3.29
Average True Range (ATR) 0.14 0.18
MACD 0.03 0.03
Stochastic Oscillator 90.08 53.17

Price Performance

Historical Comparison
HNNA
XGN

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company that manages and markets open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, multi-asset sectors, specialty products, and fixed income products. The company earns revenues mainly from investment advisory services and secondarily from shareholder services. Advisory services include managing each fund's portfolio in line with its investment objectives, monitoring compliance and performance, overseeing sub-advisors and other service providers, and handling marketing, distribution, and regulatory reporting. Shareholder services cover investor support and coordination with the fund service provider, with all related fees based on the funds' average daily net asset values.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: